NCT02429765View on ClinicalTrials.gov

Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
COPD
Interventions
DRUG

ACL/FOR

DRUG

Placebo

Trial Locations (1)

K7L 2V7

Respiratory Investigation Unit, Kingston General Hospital, Kingston

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Queen's University

OTHER